News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Venrock Healthcare Capital Partners II, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 0% stake in AXSOME THERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Trevi Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Cogent Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 9.3% stake in Inozyme Pharma, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 1.3% stake in Provention Bio, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Annexon, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 6.8% stake in GH Research PLC |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 4% stake in aTyr Pharma, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 5.6% stake in Savara Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Celcuity Inc. |
| 10/28/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/28/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 16% stake in Tricida, Inc. |
| 07/08/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/06/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 6.1% stake in Sierra Oncology, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 8% stake in VistaGen Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 5.6% stake in aTyr Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 0.5% stake in Corvus Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Cogent Biosciences, Inc. |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 2.7% stake in Athira Pharma, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/18/2020 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 11.4% stake in Unum Therapeutics Inc. |
| 04/03/2020 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 0% stake in Milestone Pharmaceuticals Inc. |
| 02/14/2020 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 7.5% stake in Marinus Pharmaceuticals, Inc. |
| 02/14/2020 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 5.5% stake in KALVISTA PHARMACEUTICALS, INC. |
| 02/14/2020 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 6.3% stake in AXSOME THERAPEUTICS, INC. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/10/2018 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 12.3% stake in KALVISTA PHARMACEUTICALS, INC. |
|
|